Description
“With a focus on research and development in the area of innovative medicines, this study discusses a new European approach to pharmaceutical policy. After examining the European pharmaceutical sector’s features, and the strengths and weaknesses of the current research and business model, the study explores the need for and the concept of a European infrastructure with a long-term transboundary mission”
Project details
On 28 September 2022, STOA organised a roundtable event to discuss the initiative to create a public European health infrastructure, proposed in a recent STOA study. The event was successful, gathering almost 100 participants in Brussels and over 200 online. It gathered a rich diversity of views, from representatives of the European Union (EU) and international bodies, civil society, academia and industry.
Click here to know more